CIDRAP newsletters options
A third mRNA vaccine dose results in fewer Omicron deaths, hospitalizations, and cases, 3 studies find.
Researchers estimate that more than 1.2 million people died from superbugs in 2019.
In a phase 3 trial, an investigational oral microbiome therapy was superior to placebo in reducing the risk of recurrent Clostridioides difficile infection, researchers reported yesterday in the New England Journal of Medicine.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
A cohort study of more than 2,000 US and Canadian women indicates that COVID-19 vaccination does not impair fertility—but men who become infected with SARS-CoV-2 may experience short-term reduced fertility, according to surveys of the women's partners.
Meanwhile, officials in Denmark and Norway say an Omicron subvariant called BA.2 is increasing rapidly.
New York, Boston, Denver, the Twin Cities, and San Diego have all likely peaked, according to sampling.
A third dose of COVID-19 vaccine successfully raises antibody levels that neutralize the Omicron variant, according to laboratory findings from UK scientists published yesterday in The Lancet.
Southeast Asia reported the steepest increase, followed by the Eastern Mediterranean region.
The nocebo effect can happen because of preconceived notions in volunteers.
The respirators will be distributed at community health centers and pharmacies across the country.
A small University of California study finds no evidence that breast milk from mothers infected with SARS-CoV-2 transmits the virus to their babies.
The study, published today in Pediatrics Research, involved polymerase chain reaction (PCR) testing of 285 samples and viral culture of 160 samples of breast milk from 110 women with confirmed or suspected COVID-19.
A new paper in Nature Communications describes the use of a pre-adapted bacteriophage in combination with antibiotics to treat a patient with a fracture-related, pandrug-resistant (PDR) Klebsiella pneumoniae infection.
Steps include launching a US international pandemic preparedness project and appointing a global health security envoy.
Though cases appear to be plateauing in some Eastern cities, hospitalizations are still high across the country.
The shortened approach achieved a similar clinical response and resolution of symptoms.
Though early-hit nations are on the downslope of their Omicron surges, others are battling rising cases.
Today a study from Germany published in Science shows three doses of the Pfizer-BioNTech COVID-19 vaccine raised antibody levels against the highly transmissible Omicron (B.1.1.529) variant.
The US Department of Agriculture (USDA) on Jan 14 announced that highly pathogenic H5N1 avian influenza was detected in a wild wigeon in South Carolina, marking the first time the Eurasian strain of the virus has been detected in the United States since 2016.
The finding follows the recent detection of high-path H5N1 in wild birds and poultry in Canada's Newfoundland and Labrador region.
After battling foreign fluctuations, Nexus Pharmaceuticals bucks convention and builds local.
